The crystallographic model of rhodopsin and its use in studies of other G protein-coupled receptors.

G protein-coupled receptors (GPCRs) are integral membrane proteins that respond to environmental signals and initiate signal transduction pathways activating cellular processes. Rhodopsin is a GPCR found in rod cells in retina where it functions as a photopigment. Its molecular structure is known from cryo-electron microscopic and X-ray crystallographic studies, and this has reshaped many structure/function questions important in vision science. In addition, this first GPCR structure has provided a structural template for studies of other GPCRs, including many known drug targets. After presenting an overview of the major structural elements of rhodopsin, recent literature covering the use of the rhodopsin structure in analyzing other GPCRs will be summarized. Use of the rhodopsin structural model to understand the structure and function of other GPCRs provides strong evidence validating the structural model.

[1]  S. Vishveshwara,et al.  Geometry of proline-containing alpha-helices in proteins. , 2009, International journal of peptide and protein research.

[2]  K. Palczewski,et al.  G protein-coupled receptor rhodopsin: a prospectus. , 2003, Annual review of physiology.

[3]  D C Teller,et al.  Crystal structure of rhodopsin: a template for cone visual pigments and other G protein-coupled receptors. , 2002, Biochimica et biophysica acta.

[4]  Krzysztof Palczewski,et al.  Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Science.

[5]  Anthony Watts,et al.  Relative orientation between the beta-ionone ring and the polyene chain for the chromophore of rhodopsin in native membranes. , 2002, Biochemistry.

[6]  K. Martin,et al.  The critical role of transmembrane prolines in human prostacyclin receptor activation. , 2002, Molecular pharmacology.

[7]  John Dunlop,et al.  The role of transmembrane helix 5 in agonist binding to the human H3 receptor. , 2002, The Journal of pharmacology and experimental therapeutics.

[8]  Francesca Fanelli,et al.  Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation. , 2002, Molecular pharmacology.

[9]  T. Lybrand,et al.  Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor. , 2002, Molecular pharmacology.

[10]  Yoshinori Shichida,et al.  Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  A. Piserchio,et al.  Structural insight into the role of the second intracellular loop of the bradykinin 2 receptor in signaling and internalization. , 2002, Biopolymers.

[12]  M. Ascoli,et al.  The lutropin/choriogonadotropin receptor, a 2002 perspective. , 2002, Endocrine reviews.

[13]  T. Sakmar,et al.  Structure of rhodopsin and the superfamily of seven-helical receptors: the same and not the same. , 2002, Current opinion in cell biology.

[14]  A. Rosenthal,et al.  Variant amino acids in the extracellular loops of murine and human vasopressin V2 receptors account for differences in cell surface expression and ligand affinity. , 2002, Molecular endocrinology.

[15]  Bryan L Roth,et al.  Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6* 210 , 2002, The Journal of Biological Chemistry.

[16]  B. Maigret,et al.  The Biologically Crucial C Terminus of Cholecystokinin and the Non-peptide Agonist SR-146,131 Share a Common Binding Site in the Human CCK1 Receptor , 2002, The Journal of Biological Chemistry.

[17]  R. Neubig,et al.  NMR Structure of the Second Intracellular Loop of the α2A Adrenergic Receptor: Evidence for a Novel Cytoplasmic Helix†,‡ , 2002 .

[18]  S. Mammi,et al.  Molecular characterization of a ligand-tethered parathyroid hormone receptor. , 2002, Biophysical chemistry.

[19]  Barbara Cacciari,et al.  Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists. , 2002, Journal of medicinal chemistry.

[20]  R. Kühne,et al.  Impact of aromatic residues within transmembrane helix 6 of the human gonadotropin-releasing hormone receptor upon agonist and antagonist binding. , 2002, Biochemistry.

[21]  J. Wess,et al.  Conformational Changes That Occur during M3Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross-linking Strategy* , 2002, The Journal of Biological Chemistry.

[22]  A. Scheer,et al.  Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling. , 2001, The Journal of biological chemistry.

[23]  T. Bürckstümmer,et al.  Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists. , 2001, Molecular pharmacology.

[24]  J. Klein-Seetharaman,et al.  Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. , 2001, Biochemistry.

[25]  J. Klein-Seetharaman,et al.  Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 65 in helix TM1 and residues in the sequence 306-319 at the cytoplasmic end of helix TM7 and in helix H8. , 2001, Biochemistry.

[26]  K. Jacobson,et al.  Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. , 2001, Journal of medicinal chemistry.

[27]  L. Pardo,et al.  3-D-QSAR/CoMFA and recognition models of benzimidazole derivatives at the 5-HT(4) receptor. , 2001, Bioorganic & medicinal chemistry letters.

[28]  B. Maigret,et al.  Control of Conformational Equilibria in the Human B2 Bradykinin Receptor , 2001, The Journal of Biological Chemistry.

[29]  E. Meng,et al.  Receptor activation: what does the rhodopsin structure tell us? , 2001, Trends in pharmacological sciences.

[30]  J. Rosenbusch,et al.  Stability of membrane proteins: relevance for the selection of appropriate methods for high-resolution structure determinations. , 2001, Journal of structural biology.

[31]  J. Klein-Seetharaman,et al.  Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acids deduced from spontaneous disulfide bond formation between Cys316 and engineered cysteines in cytoplasmic loop 1. , 2001, Biochemistry.

[32]  H Weinstein,et al.  Functional role of a conserved motif in TM6 of the rat mu opioid receptor: constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp. , 2001, Biochemistry.

[33]  H. Weinstein,et al.  Constitutive activation of the mu opioid receptor by mutation of D3.49(164), but not D3.32(147): D3.49(164) is critical for stabilization of the inactive form of the receptor and for its expression. , 2001, Biochemistry.

[34]  Georgios G. Gkoutos,et al.  Lipid-facing correlated mutations and dimerization in G-protein coupled receptors. , 2001, Protein engineering.

[35]  R. Jensen,et al.  Molecular Basis for Selectivity of High Affinity Peptide Antagonists for the Gastrin-releasing Peptide Receptor* , 2001, The Journal of Biological Chemistry.

[36]  J. Klein-Seetharaman,et al.  Probing the dark state tertiary structure in the cytoplasmic domain of rhodopsin: proximities between amino acids deduced from spontaneous disulfide bond formation between cysteine pairs engineered in cytoplasmic loops 1, 3, and 4. , 2001, Biochemistry.

[37]  G R Marshall,et al.  3D model for TM region of the AT-1 receptor in complex with angiotensin II independently validated by site-directed mutagenesis data. , 2001, Biochemical and biophysical research communications.

[38]  Gregory Choi,et al.  Studies on the structure of the G-protein-coupled receptor rhodopsin including the putative G-protein binding site in unactivated and activated forms. , 2001, Biochemistry.

[39]  J. Ballesteros,et al.  G protein-coupled receptor drug discovery: implications from the crystal structure of rhodopsin. , 2001, Current opinion in drug discovery & development.

[40]  F. Glaser,et al.  Modeling the 3D structure of GPCRs from sequence , 2001, Medicinal research reviews.

[41]  K. Jacobson,et al.  Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking. , 2001, Journal of medicinal chemistry.

[42]  J. Fahrenkrug,et al.  Functional roles of conserved transmembrane prolines in the human VPAC1 receptor , 2001, FEBS letters.

[43]  S. Moro,et al.  Fluorosulfonyl- and bis-(beta-chloroethyl)amino-phenylamino functionalized pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives: irreversible antagonists at the human A3 adenosine receptor and molecular modeling studies. , 2001, Journal of medicinal chemistry.

[44]  C. S. Gal,et al.  Single Amino Acid Substitutions and Deletions That Alter the G Protein Coupling Properties of the V2 Vasopressin Receptor Identified in Yeast by Receptor Random Mutagenesis* , 2001, The Journal of Biological Chemistry.

[45]  J. Ballesteros,et al.  Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.

[46]  K. Neve,et al.  Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor. , 2001, Molecular pharmacology.

[47]  K. Palczewski,et al.  Crystal structure of rhodopsin: implications for vision and beyond. , 2001, Current opinion in structural biology.

[48]  L. Miller,et al.  Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies , 2001, Peptides.

[49]  L. Pardo,et al.  Study of the bioactive conformation of novel 5-HT4 receptor ligands: influence of an intramolecular hydrogen bond , 2001 .

[50]  S. Firestein,et al.  Length analyses of mammalian G-protein-coupled receptors. , 2001, Journal of theoretical biology.

[51]  P. Gonzalez-Cabrera,et al.  Phe-308 and Phe-312 in transmembrane domain 7 are major sites of alpha 1-adrenergic receptor antagonist binding. Imidazoline agonists bind like antagonists. , 2001, The Journal of biological chemistry.

[52]  D C Teller,et al.  Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs). , 2001, Biochemistry.

[53]  J. Ballesteros,et al.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.

[54]  S. Wodak,et al.  A Conserved Asn in Transmembrane Helix 7 Is an On/Off Switch in the Activation of the Thyrotropin Receptor* , 2001, The Journal of Biological Chemistry.

[55]  H. Weinstein,et al.  Comparison of the amino acid residues in the sixth transmembrane domains accessible in the binding-site crevices of mu, delta, and kappa opioid receptors. , 2001, Biochemistry.

[56]  K. Nakamura,et al.  Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness. , 2001, Molecular endocrinology.

[57]  Y. Wan,et al.  Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. , 2001, Biochemistry.

[58]  K. Palczewski,et al.  Activation of rhodopsin: new insights from structural and biochemical studies. , 2001, Trends in biochemical sciences.

[59]  E. Dawson,et al.  Determination of amino acid residues that are accessible from the ligand binding crevice in the seventh transmembrane-spanning region of the human A(1) adenosine receptor. , 2001, Molecular pharmacology.

[60]  T. Spalding,et al.  Constitutively active muscarinic receptors. , 2001, Life sciences.

[61]  T. Schwartz,et al.  Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor* , 2001, The Journal of Biological Chemistry.

[62]  J. Saldanha,et al.  Multiple allosteric sites on muscarinic receptors. , 2001, Life sciences.

[63]  H. Hamm.  How activated receptors couple to G proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  Shoshana J. Wodak,et al.  The TXP Motif in the Second Transmembrane Helix of CCR5 , 2001, The Journal of Biological Chemistry.

[65]  R. Birge,et al.  Conformation and orientation of the retinyl chromophore in rhodopsin: a critical evaluation of recent NMR data on the basis of theoretical calculations results in a minimum energy structure consistent with all experimental data. , 2001, Biochemistry.

[66]  J. Schwartz,et al.  Different antagonist binding properties of human and rat histamine H3 receptors. , 2001, Bioorganic & medicinal chemistry letters.

[67]  J. Adelman,et al.  ATP-dependent Activation of the Intermediate Conductance, Ca2+-activated K+ Channel, hIK1, Is Conferred by a C-terminal Domain* , 2001, The Journal of Biological Chemistry.

[68]  D. Mierke,et al.  Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin-2 receptor. , 2001, Biochemistry.

[69]  A. Themmen,et al.  Lutropin Receptor Function: Insights from Natural, Engineered, and Computer‐Simulated Mutations , 2001, IUBMB life.

[70]  Robert M. Graham,et al.  Non-α-helical elements modulate polytopic membrane protein architecture , 2001 .

[71]  Elaine C. Meng,et al.  An Activation Switch in the Ligand Binding Pocket of the C5a Receptor* , 2001, The Journal of Biological Chemistry.

[72]  R. Osman,et al.  Charged Residues at the Intracellular Boundary of Transmembrane Helices 2 and 3 Independently Affect Constitutive Activity of Kaposi's Sarcoma-associated Herpesvirus G Protein-coupled Receptor* , 2001, The Journal of Biological Chemistry.

[73]  T. Sakmar,et al.  Rhodopsin: structural basis of molecular physiology. , 2001, Physiological reviews.

[74]  J S Mills,et al.  Characterization of the Binding Site on the Formyl Peptide Receptor Using Three Receptor Mutants and Analogs of Met-Leu-Phe and Met-Met-Trp-Leu-Leu* , 2000, The Journal of Biological Chemistry.

[75]  T. Gudermann,et al.  Requirement of Specific Intrahelical Interactions for Stabilizing the Inactive Conformation of Glycoprotein Hormone Receptors* , 2000, The Journal of Biological Chemistry.

[76]  M. Tota,et al.  Molecular determinants of ligand binding to the human melanocortin-4 receptor. , 2000, Biochemistry.

[77]  J. Ballesteros,et al.  The first transmembrane segment of the dopamine D2 receptor: accessibility in the binding-site crevice and position in the transmembrane bundle. , 2000, Biochemistry.

[78]  Lakshmi A Devi,et al.  Dimerization of G-Protein Coupled Receptors , 2000, Neuropsychopharmacology.

[79]  H Weinstein,et al.  Prokink: a protocol for numerical evaluation of helix distortions by proline. , 2000, Protein engineering.

[80]  S. Subramaniam,et al.  Crystallographic analysis of protein conformational changes in the bacteriorhodopsin photocycle. , 2000, Biochimica et biophysica acta.

[81]  K. Nakanishi,et al.  Movement of retinal along the visual transduction path. , 2000, Science.

[82]  K. Palczewski,et al.  X-Ray diffraction analysis of three-dimensional crystals of bovine rhodopsin obtained from mixed micelles. , 2000, Journal of structural biology.

[83]  P. Yeagle,et al.  Solution structure of the sixth transmembrane helix of the G-protein-coupled receptor, rhodopsin. , 2000, Biochimica et biophysica acta.

[84]  Karl Edman,et al.  High-resolution X-ray structure of an early intermediate in the bacteriorhodopsin photocycle , 1999, Nature.

[85]  H Luecke,et al.  Structure of bacteriorhodopsin at 1.55 A resolution. , 1999, Journal of molecular biology.

[86]  J. Ballesteros,et al.  The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. , 1999, Biophysical journal.

[87]  Y. Shichida,et al.  Visual pigment: G-protein-coupled receptor for light signals , 1998, Cellular and Molecular Life Sciences CMLS.

[88]  R. Hubbard,et al.  Combined biophysical and biochemical information confirms arrangement of transmembrane helices visible from the three-dimensional map of frog rhodopsin. , 1998, Journal of molecular biology.

[89]  Frank Terstegen,et al.  ABSOLUTE SENSE OF TWIST OF THE C12-C13 BOND OF THE RETINAL CHROMOPHORE IN RHODOPSIN : SEMIEMPIRICAL AND NONEMPIRICAL CALCULATIONS OF CHIROPTICAL DATA , 1998 .

[90]  Robert J. Lefkowitz,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[91]  B. Kobilka,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[92]  Martha Vaughan.  G Protein-coupled Receptors Minireview Series* , 1998, The Journal of Biological Chemistry.

[93]  M. Grossmann,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[94]  H Luecke,et al.  Proton transfer pathways in bacteriorhodopsin at 2.3 angstrom resolution. , 1998, Science.

[95]  T. Kouyama,et al.  Highly Selective Separation of Rhodopsin from Bovine Rod Outer Segment Membranes Using Combination of Divalent Cation and Alkyl(thio)glucoside , 1998, Photochemistry and photobiology.

[96]  K. Nakanishi,et al.  Absolute Sense of Twist of the C12C13 Bond of the Retinal Chromophore in Bovine Rhodopsin Based on Exciton‐Coupled CD Spectra of 11,12‐Dihydroretinal Analogues , 1997 .

[97]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[98]  E. Pebay-Peyroula,et al.  X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. , 1997, Science.

[99]  Gebhard F. X. Schertler,et al.  Arrangement of rhodopsin transmembrane α-helices , 1997, Nature.

[100]  A. Watts,et al.  A distance measurement between specific sites on the cytoplasmic surface of bovine rhodopsin in rod outer segment disk membranes. , 1997, Biochimica et biophysica acta.

[101]  A. Lomize,et al.  The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints. , 1997, Biophysical journal.

[102]  K. Palczewski,et al.  Turned on by Ca2+! The physiology and pathology of Ca2+-binding proteins in the retina , 1996, Trends in Neurosciences.

[103]  G. Fain,et al.  Dark adaptation in vertebrate photoreceptors , 1996, Trends in Neurosciences.

[104]  M. Billeter,et al.  MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.

[105]  S. Watson,et al.  The G-Protein Linked Receptor Facts Book , 1994 .

[106]  Gebhard F. X. Schertler,et al.  Projection structure of rhodopsin , 1993, Nature.

[107]  P. Hargrave,et al.  Rhodopsin and phototransduction: a model system for G protein‐linked receptors , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[108]  J. Thornton,et al.  Influence of proline residues on protein conformation. , 1991, Journal of molecular biology.

[109]  Dudley H. Williams,et al.  The influence of proline residues on α‐helical structure , 1990 .

[110]  Richard Henderson,et al.  A model for the structure of bacteriorhodopsin based on high resolution electron cryomicroscopy , 1990 .

[111]  R. Henderson,et al.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.

[112]  J. Thornton,et al.  Helix geometry in proteins. , 1988, Journal of molecular biology.

[113]  H. Khorana,et al.  Magic angle spinning nuclear magnetic resonance of isotopically labeled rhodopsin. , 2002, Methods in enzymology.

[114]  J. Bockaert,et al.  G protein-coupled receptors: dominant players in cell-cell communication. , 2002, International review of cytology.

[115]  T. Sakmar,et al.  Rhodopsin: insights from recent structural studies. , 2002, Annual review of biophysics and biomolecular structure.

[116]  S. Moro,et al.  Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists. , 2002, Journal of medicinal chemistry.

[117]  R. Neubig,et al.  NMR structure of the second intracellular loop of the alpha 2A adrenergic receptor: evidence for a novel cytoplasmic helix. , 2002, Biochemistry.

[118]  Harel Weinstein,et al.  Three-dimensional representations of G protein-coupled receptor structures and mechanisms. , 2002, Methods in enzymology.

[119]  G. Liapakis,et al.  Use of the substituted cysteine accessibility method to study the structure and function of G protein-coupled receptors. , 2002, Methods in enzymology.

[120]  Ilya A Vakser,et al.  Strategies for modeling the interactions of transmembrane helices of G protein-coupled receptors by geometric complementarity using the GRAMM computer algorithm. , 2002, Methods in enzymology.

[121]  J Novotny,et al.  Non-alpha-helical elements modulate polytopic membrane protein architecture. , 2001, Journal of molecular biology.

[122]  Gert Vriend,et al.  Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems , 2001, Nucleic Acids Res..

[123]  G R Marshall,et al.  Peptide interactions with G-protein coupled receptors. , 2001, Biopolymers.

[124]  R. Osman,et al.  Minireview: Insights into G protein-coupled receptor function using molecular models. , 2001, Endocrinology.

[125]  G R Marshall,et al.  Novel approach to computer modeling of seven-helical transmembrane proteins: current progress in the test case of bacteriorhodopsin. , 2001, Acta biochimica Polonica.

[126]  R. Osman,et al.  Minireview: Insights into G Protein-Coupled Receptor Function Using Molecular Models* * The work from our laboratories was supported by USPHS Grant DK-43036. , 2001, Endocrinology.

[127]  K. Chaturvedi,et al.  Structure and regulation of opioid receptors. , 2000, Biopolymers.

[128]  R. Mathies,et al.  Chapter 2 The primary photoreaction of rhodopsin , 2000 .

[129]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[130]  K. Palczewski.  Vertebrate phototransduction and the visual cycle , 2000 .

[131]  H. Philippe,et al.  How color visual pigments are tuned , 1999 .

[132]  J. Baldwin,et al.  Arrangement of rhodopsin transmembrane alpha-helices. , 1997, Nature.

[133]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .